These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 79265)

  • 1. Investigations on the efficacy of two schemes of standard gammaglobulin administration in the prevention of viral hepatitis.
    Zavate O; Ionescu T; Ivan A; Popa S; Angheluţá A; Ungureanu A; Ignea C; Avram G
    Virologie; 1978; 29(2):155-60. PubMed ID: 79265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Our experience in viral hepatitis (VH) immunoglobulin prophylaxis.
    Zavate O; Ivan A; Avram G; Ungureanu A; Cotor F
    Dev Biol Stand; 1983; 54():423-7. PubMed ID: 6653897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological investigations on viral hepatitis in preschool and school communities. Note II. Evaluation of the prophylactic efficiency of standard gammaglobulin administration.
    Pănoiu L; Dobrescu A; Petrescu R; Sternberg I; Dinescu G; Ionescu C; Bărbulescu V; Both R
    Virologie; 1979; 30(2):103-7. PubMed ID: 88794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the protection conferred against viral hepatitis by the administration of standard gammaglobulin in prophylactic doses.
    Pănoiu L; Dobrescu A; Drăgoi V; Avram I; Ciureş Z; Bordeianu V; Bărbulescu V; Both R
    Virologie; 1980; 31(2):91-4. PubMed ID: 6157246
    [No Abstract]   [Full Text] [Related]  

  • 5. [Subclinical forms of viral hepatitis in closed collectives of children].
    Burlea-Iriciuc A; Ivan A; Ungureanu A; Apostol S; Macovei O
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(4):617-20. PubMed ID: 2872710
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficiency of normal human immunoglobulins in the prevention of infectious hepatitis].
    Spînu I; Zavate O; Constantinesco N; Manta I; Avram G; Buzdugan I; Vîrnă G; Ghibu F; Dumitriu G
    Arch Roum Pathol Exp Microbiol; 1968 Dec; 27(4):883-92. PubMed ID: 4193082
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mass administration of small doses of gamma globulin for prevention of viral hepatitis].
    Adamus J
    Przegl Epidemiol; 1984; 38(4):409-17. PubMed ID: 6085409
    [No Abstract]   [Full Text] [Related]  

  • 8. [Two decades of epidemiologic surveillance of the evolution of viral hepatitis in Iaşi County (1971-1990)].
    Ivan A; Pisică G; Mitroi I; Azoicăi D; Butcovan D; Crivăţ A
    Rev Med Chir Soc Med Nat Iasi; 1992; 96(3-4):189-94. PubMed ID: 1344854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A three-year survey of viral hepatitis in West London.
    Stewart JS; Farrow LJ; Clifford RE; Lamb SG; Coghill NF; Lindon RL; Sanderson IM; Dodd PA; Smith HG; Preece JW; Zuckerman AJ
    Q J Med; 1978 Jul; 47(187):365-84. PubMed ID: 715174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution to the task of reducing the incidence of post transfusion non-A, non-B hepatitis].
    Hernández Sánchez MC; Vila Enriquez P; Alvarez Hernández M
    Sangre (Barc); 1989 Jun; 34(3):248-9. PubMed ID: 2503897
    [No Abstract]   [Full Text] [Related]  

  • 11. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence of viral hepatitis after pre- and post-seasonal administration of gamma globulin].
    Rozwoda J
    Przegl Epidemiol; 1982; 36(3-4):237-41. PubMed ID: 6184751
    [No Abstract]   [Full Text] [Related]  

  • 13. Surveillance for acute viral hepatitis--United States, 2006.
    Wasley A; Grytdal S; Gallagher K;
    MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-A, non-B hepatitis after intravenous gammaglobulin.
    Lever AM; Webster AD; Brown D; Thomas HC
    Lancet; 1985 Mar; 1(8428):587. PubMed ID: 2579302
    [No Abstract]   [Full Text] [Related]  

  • 15. [Currently available means for the prevention of post-transfusion hepatitis and criteria for their application].
    Bedarida G; Cambiè G; D'Agostino F; Sterza G
    Ric Clin Lab; 1984; 14 Suppl 1():37-60. PubMed ID: 6429830
    [No Abstract]   [Full Text] [Related]  

  • 16. [Incidence and dynamics of AgHBs in different clinical forms of viral hepatitis].
    Vâţă A; Zavate O; Dănilă F; Ungureanu A
    Rev Med Chir Soc Med Nat Iasi; 1978; 82(2):265-7. PubMed ID: 705124
    [No Abstract]   [Full Text] [Related]  

  • 17. [Epidemic of viral hepatitis in a mountain community of western Sicily].
    Intonazzo V; La Rosa G; Lanza A; Famà B; Vazzana G; Romano N; Oliveri R
    Boll Ist Sieroter Milan; 1982 May; 61(2):144-50. PubMed ID: 6289849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Various epidemiological principles of the spread of viral hepatitis in the Astrakhan district].
    Zlobina LV; Levitskiĭ VM
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Apr; (4):131-4. PubMed ID: 80899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiology of viral hepatitis in Algeria].
    Khalfa S; Ardjoun H
    Med Trop (Mars); 1984; 44(3):247-52. PubMed ID: 6438432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of the jaundice-free and subclinical forms of serum hepatitis type B in children].
    Shakhgil'dian IV; Paktoris EA; Mikhaliuk VP; Shumkina OB; Braginiskiĭ DM
    Sov Med; 1980; (10):88-90. PubMed ID: 6969446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.